K O Pryor1, J C Root2, M Mehta3, E Stern4, H Pan4, R A Veselis3, D A Silbersweig4. 1. Department of Anesthesiology, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA Department of Anesthesia and Critical Care, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA kap9009@med.cornell.edu. 2. Department of Anesthesiology, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA Department of Anesthesia and Critical Care, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. 3. Department of Anesthesia and Critical Care, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. 4. Functional Neuroimaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, 824 Boylston Street, Chestnut Hill, MA 02467, USA.
Abstract
BACKGROUND: Subclinical doses of propofol produce anterograde amnesia, characterized by an early failure of memory consolidation. It is unknown how propofol affects the amygdala-dependent emotional memory system, which modulates consolidation in the hippocampus in response to emotional arousal and neurohumoral stress. We present an event-related functional magnetic resonance imaging study of the effects of propofol on the emotional memory system in human subjects. METHODS:Thirty-five healthy subjects were randomized to receive propofol, at an estimated brain concentration of 0.90 μg ml(-1), or placebo. During drug infusion, emotionally arousing and neutral images were presented in a continuous recognition task, while blood-oxygen-level-dependent activation responses were acquired. After a drug-free interval of 2 h, subsequent memory for successfully encoded items was assessed. Imaging analysis was performed using statistical parametric mapping and behavioural analysis using signal detection models. RESULTS:Propofol had no effect on the stereotypical amygdalar response to emotional arousal, but caused marked suppression of the hippocampal response. Propofol caused memory performance to become uncoupled from amygdalar activation, but it remained correlated with activation in the posterior hippocampus, which decreased in proportion to amnesia. CONCLUSIONS:Propofol is relatively ineffective at suppressing amygdalar activation at sedative doses, but abolishes emotional modulation and causes amnesia via mechanisms that commonly involve hyporesponsiveness of the hippocampus. These findings raise the possibility that amygdala-dependent fear systems may remain intact even when a patient has diminished memory of events. This may be of clinical importance in the perioperative development of fear-based psychopathologies, such as post-traumatic stress disorder. CLINICAL TRIAL REGISTRATION: NCT00504894.
RCT Entities:
BACKGROUND: Subclinical doses of propofol produce anterograde amnesia, characterized by an early failure of memory consolidation. It is unknown how propofol affects the amygdala-dependent emotional memory system, which modulates consolidation in the hippocampus in response to emotional arousal and neurohumoral stress. We present an event-related functional magnetic resonance imaging study of the effects of propofol on the emotional memory system in human subjects. METHODS: Thirty-five healthy subjects were randomized to receive propofol, at an estimated brain concentration of 0.90 μg ml(-1), or placebo. During drug infusion, emotionally arousing and neutral images were presented in a continuous recognition task, while blood-oxygen-level-dependent activation responses were acquired. After a drug-free interval of 2 h, subsequent memory for successfully encoded items was assessed. Imaging analysis was performed using statistical parametric mapping and behavioural analysis using signal detection models. RESULTS:Propofol had no effect on the stereotypical amygdalar response to emotional arousal, but caused marked suppression of the hippocampal response. Propofol caused memory performance to become uncoupled from amygdalar activation, but it remained correlated with activation in the posterior hippocampus, which decreased in proportion to amnesia. CONCLUSIONS:Propofol is relatively ineffective at suppressing amygdalar activation at sedative doses, but abolishes emotional modulation and causes amnesia via mechanisms that commonly involve hyporesponsiveness of the hippocampus. These findings raise the possibility that amygdala-dependent fear systems may remain intact even when a patient has diminished memory of events. This may be of clinical importance in the perioperative development of fear-based psychopathologies, such as post-traumatic stress disorder. CLINICAL TRIAL REGISTRATION: NCT00504894.
Authors: Misha Perouansky; Vinuta Rau; Tim Ford; S Irene Oh; Mark Perkins; Edmond I Eger; Robert A Pearce Journal: Anesthesiology Date: 2010-12 Impact factor: 7.892
Authors: Kane O Pryor; Ruth A Reinsel; Meghana Mehta; Yuelin Li; John T Wixted; Robert A Veselis Journal: Anesthesiology Date: 2010-08 Impact factor: 7.892
Authors: Kaike K Kaisti; Jaakko W Långsjö; Sargo Aalto; Vesa Oikonen; Hannu Sipilä; Mika Teräs; Susanna Hinkka; Liisa Metsähonkala; Harry Scheinin Journal: Anesthesiology Date: 2003-09 Impact factor: 7.892
Authors: Keith M Vogt; James W Ibinson; C Tyler Smith; Ally T Citro; Caroline M Norton; Helmet T Karim; Vencislav Popov; Aman Mahajan; Howard J Aizenstein; Lynne M Reder; Julie A Fiez Journal: Anesthesiology Date: 2021-07-01 Impact factor: 8.986
Authors: Ana Galarza Vallejo; Marijn C W Kroes; Enrique Rey; Maria Victoria Acedo; Stephan Moratti; Guillén Fernández; Bryan A Strange Journal: Sci Adv Date: 2019-03-20 Impact factor: 14.136
Authors: Daa Un Moon; Nazli Esfahani-Bayerl; Carsten Finke; Daniel J Salchow; Mario Menk; Simon Bayerl; Richard Kempter; Christoph J Ploner Journal: eNeuro Date: 2020-06-19
Authors: Signe Sloth Madsen; Kirsten Møller; Karsten Skovgaard Olsen; Mark Bitsch Vestergaard; Ulrich Lindberg; Henrik Bo Wiberg Larsson; Johan Mårtensson; Mads U Werner; Sofia Alexandra Gaspar Santos; Mohammad Sohail Asghar Journal: Trials Date: 2020-09-22 Impact factor: 2.279